Application | Comment | Organism |
---|---|---|
medicine | ADAM-17 is a putative target for treatment of neuroinflammatory diseases | Homo sapiens |
medicine | ADAM-17 is a putative target for treatment of neuroinflammatory diseases | Rattus norvegicus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Rattus norvegicus | - |
female, Lewis | - |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
nerve | sural nerve biopsies from Guillain-Barre syndrome patients. ADAM-17-expressing T cells can be localized primarily within the epi- and perineurium, whereas in control sections from patients with non-inflammatory neuropathies, no axpression can be depected. The enzyme may contribute to the pathogenesis of inflammatory demyelination of the peripheral nervous system | Homo sapiens | - |
T-cell | primary cellular source of ADAM-17 in inflamed peripheral nervous system (experimental autoimmune neuritis). Not all T lymphocytes within the inflamed peripheral nervous system express ADAM-17. No ADAM-17 expressing cells are found in nerves from control animals | Rattus norvegicus | - |